Pacific Biosciences Of California Quick Ratio 2010-2024 | PACB

Historical quick ratio values for Pacific Biosciences Of California (PACB) over the last 10 years.
Pacific Biosciences Of California Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2024-03-31 $0.61B $0.07B 8.36
2023-12-31 $0.69B $0.10B 7.21
2023-09-30 $0.81B $0.18B 4.43
2023-06-30 $0.87B $0.27B 3.20
2023-03-31 $0.92B $0.27B 3.46
2022-12-31 $0.80B $0.26B 3.04
2022-09-30 $0.87B $0.08B 10.66
2022-06-30 $0.93B $0.08B 11.07
2022-03-31 $1.00B $0.06B 16.38
2021-12-31 $1.08B $0.07B 15.01
2021-09-30 $1.11B $0.06B 19.99
2021-06-30 $1.17B $0.05B 25.78
2021-03-31 $1.18B $0.03B 34.97
2020-12-31 $0.34B $0.04B 8.87
2020-09-30 $0.22B $0.13B 1.72
2020-06-30 $0.13B $0.13B 1.03
2020-03-31 $0.15B $0.13B 1.16
2019-12-31 $0.07B $0.05B 1.38
2019-09-30 $0.06B $0.05B 1.22
2019-06-30 $0.08B $0.05B 1.65
2019-03-31 $0.09B $0.05B 2.06
2018-12-31 $0.11B $0.03B 4.23
2018-09-30 $0.12B $0.02B 5.74
2018-06-30 $0.07B $0.02B 3.28
2018-03-31 $0.09B $0.03B 3.60
2017-12-31 $0.08B $0.03B 2.74
2017-09-30 $0.10B $0.03B 3.15
2017-06-30 $0.12B $0.04B 3.24
2017-03-31 $0.07B $0.04B 2.06
2016-12-31 $0.09B $0.03B 2.77
2016-09-30 $0.11B $0.03B 3.30
2016-06-30 $0.12B $0.03B 3.66
2016-03-31 $0.11B $0.03B 3.34
2015-12-31 $0.10B $0.04B 2.61
2015-09-30 $0.08B $0.04B 1.93
2015-06-30 $0.08B $0.04B 2.01
2015-03-31 $0.09B $0.04B 2.24
2014-12-31 $0.11B $0.03B 3.38
2014-09-30 $0.10B $0.03B 3.53
2014-06-30 $0.11B $0.03B 3.95
2014-03-31 $0.12B $0.02B 5.50
2013-12-31 $0.12B $0.02B 5.16
2013-09-30 $0.13B $0.02B 5.87
2013-06-30 $0.11B $0.02B 7.41
2013-03-31 $0.12B $0.01B 8.53
2012-12-31 $0.11B $0.02B 7.15
2012-09-30 $0.12B $0.01B 8.96
2012-06-30 $0.14B $0.02B 9.54
2012-03-31 $0.17B $0.02B 8.33
2011-12-31 $0.18B $0.02B 9.50
2011-09-30 $0.20B $0.02B 9.47
2011-06-30 $0.23B $0.02B 10.49
2011-03-31 $0.25B $0.02B 10.39
2010-12-31 $0.29B $0.02B 13.74
2010-09-30 $0.00B $0.02B 0.00
2010-06-30 $0.00B 0.00
2010-03-31 $0.00B 0.00
2009-12-31 $0.00B 0.00
2009-09-30 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.496B $0.201B
Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $219.827B 26.64
Intuitive Surgical (ISRG) United States $148.541B 89.48
Edwards Lifesciences (EW) United States $52.426B 34.12
DexCom (DXCM) United States $46.489B 70.42
Alcon (ALC) Switzerland $44.690B 32.03
IDEXX Laboratories (IDXX) United States $41.806B 49.00
IQVIA Holdings (IQV) United States $39.266B 22.78
STERIS (STE) Ireland $22.296B 26.03
SONOVA HOLDING (SONVY) Switzerland $19.142B 0.00
Waters (WAT) United States $17.826B 26.20
Hologic (HOLX) United States $17.013B 19.03
Fresenius Medical Care AG KGaA (FMS) Germany $12.312B 14.37
Sysmex ADR (SSMXY) Japan $10.460B 32.80
Teleflex (TFX) United States $9.729B 15.14
Globus Medical (GMED) United States $8.954B 26.25
Penumbra (PEN) United States $7.363B 83.67
Masimo (MASI) United States $6.592B 37.97
Glaukos (GKOS) United States $5.700B 0.00
TransMedics (TMDX) United States $4.579B 434.47
Integer Holdings (ITGR) United States $3.932B 23.75
PROCEPT BioRobotics (PRCT) United States $3.449B 0.00
Tandem Diabetes Care (TNDM) United States $3.125B 0.00
LivaNova (LIVN) United Kingdom $2.803B 16.64
Inari Medical (NARI) United States $2.766B 0.00
Nihon Kohden (NHNKY) Japan $2.647B 14.02
Elekta AB (EKTAY) Sweden $2.426B 18.60
Integra LifeSciences Holdings (IART) United States $2.294B 10.00
RxSight (RXST) United States $2.128B 0.00
Veracyte (VCYT) United States $1.628B 0.00
Alphatec Holdings (ATEC) United States $1.448B 0.00
Artivion (AORT) United States $0.976B 93.60
OPKO Health (OPK) United States $0.920B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.905B 17.60
Silk Road Medical (SILK) United States $0.874B 0.00
Pulse Biosciences (PLSE) United States $0.775B 0.00
OrthoPediatrics (KIDS) United States $0.710B 0.00
Paragon 28 (FNA) United States $0.549B 0.00
SiBone (SIBN) United States $0.541B 0.00
IRadimed (IRMD) United States $0.541B 30.31
Mesa Laboratories (MLAB) United States $0.516B 15.29
ORTHOFIX MEDICAL INC (OFIX) United States $0.471B 0.00
Treace Medical Concepts (TMCI) United States $0.363B 0.00
Nevro (NVRO) United States $0.340B 0.00
Sight Sciences (SGHT) United States $0.333B 0.00
AxoGen (AXGN) United States $0.323B 0.00
Tactile Systems Technology (TCMD) United States $0.288B 9.86
Semler Scientific (SMLR) United States $0.281B 14.24
AngioDynamics (ANGO) United States $0.256B 0.00
908 Devices (MASS) United States $0.208B 0.00
CVRx (CVRX) United States $0.206B 0.00
EDAP TMS S.A (EDAP) France $0.197B 0.00
Inogen (INGN) United States $0.195B 0.00
Delcath Systems (DCTH) United States $0.191B 0.00
NeuroPace (NPCE) United States $0.184B 0.00
Accuray (ARAY) United States $0.177B 0.00
Alpha Tau Medical (DRTS) Israel $0.162B 0.00
ClearPoint Neuro (CLPT) United States $0.157B 0.00
Atossa Genetics (ATOS) United States $0.156B 0.00
Yubo Biotech (YBGJ) China $0.110B 0.00
KORU Medical Systems (KRMD) United States $0.105B 0.00
Spectral Diagnostics (EDTXF) Canada $0.102B 0.00
Sensus Healthcare (SRTS) United States $0.093B 19.66
Monogram Orthopaedics (MGRM) United States $0.069B 0.00
InspireMD (NSPR) Israel $0.067B 0.00
Hyperfine (HYPR) United States $0.065B 0.00
EnVVeno Medical (NVNO) United States $0.063B 0.00
Neuronetics (STIM) United States $0.060B 0.00
SEP Acquisition (SEPA) United States $0.058B 0.00
LENSAR (LNSR) United States $0.055B 0.00
Envoy Medical (COCH) United States $0.049B 0.00
Vicarious Surgical (RBOT) United States $0.043B 0.00
T2 Biosystems (TTOO) United States $0.041B 0.00
ReWalk Robotics (LFWD) Israel $0.040B 0.00
DarioHealth (DRIO) United States $0.039B 0.00
Precision Optics (POCI) United States $0.038B 0.00
Lucid Diagnostics (LUCD) United States $0.038B 0.00
Rapid Micro Biosystems (RPID) United States $0.033B 0.00
Spectral AI (MDAI) United States $0.030B 0.00
Accelerate Diagnostics (AXDX) United States $0.028B 0.00
Pixie Dust Technologies (PXDT) Japan $0.027B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.025B 0.00
Aspira Women's Health (AWH) United States $0.025B 0.00
Autonomix Medical (AMIX) United States $0.022B 0.00
Ekso Bionics Holdings (EKSO) United States $0.020B 0.00
Microbot Medical (MBOT) United States $0.015B 0.00
QT Imaging Holdings (QTI) United States $0.015B 0.00
NexGel (NXGL) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
PAVmed (PAVM) United States $0.011B 0.00
Venus Concept (VERO) Canada $0.007B 0.00
Biosig Technologies (BSGM) United States $0.006B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
ENDRA Life Sciences (NDRA) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00